Clinical Trial: A Study to Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants.

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07016464) titled 'A Study to Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants.' on May 23.

Brief Summary: This study is testing if the medicine REM0045392 is safe and well-tolerated. It also looks at whether food affects how the medicine works.

The medicine will be tested in Healthy men (Part 1 and 2) and Healthy Older men and women (Part 3).

Participants will take the medicine once (in Part 1) or during 10 days (in Part 2 and 3), with increasing doses.

REM0045392 is being developed as a treatment for Alzheimer's disease.

Study Start Date: March 20

Study Type: INTERVENTIONAL

Condi...